The Evolution of Antiplatelet Therapy in the Treatment of Acute Coronary Syndromes
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Evolution of Antiplatelet Therapy in the Treatment of Acute Coronary Syndromes
Authors
Keywords
-
Journal
DRUGS
Volume 72, Issue 16, Pages 2087-2116
Publisher
Springer Nature
Online
2012-10-20
DOI
10.2165/11640880-000000000-00000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduced immediate ischemic events with cangrelor in PCI: A pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction
- (2012) Harvey D. White et al. AMERICAN HEART JOURNAL
- ARC15105 Is a Potent Antagonist of Von Willebrand Factor Mediated Platelet Activation and Adhesion
- (2012) Jolanta M. Siller-Matula et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and a History of Stroke or Transient Ischemic Attack
- (2012) Stefan K. James et al. CIRCULATION
- New Directions in Antiplatelet Therapy
- (2012) José Luis Ferreiro et al. Circulation-Cardiovascular Interventions
- Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery
- (2012) Dominick J. Angiolillo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis
- (2012) J.-L. RENY et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Vorapaxar in the Secondary Prevention of Atherothrombotic Events
- (2012) David A. Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of ticagrelor versus clopidogrel on high on-treatment platelet reactivity: Combined analysis of the ONSET/OFFSET and RESPOND studies
- (2011) Kevin P. Bliden et al. AMERICAN HEART JOURNAL
- Pulmonary Function in Patients With Acute Coronary Syndrome Treated With Ticagrelor or Clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] Pulmonary Function Substudy)
- (2011) Robert F. Storey et al. AMERICAN JOURNAL OF CARDIOLOGY
- Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy
- (2011) Timothy D. Warner et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
- (2011) Jeffrey L. Anderson et al. CIRCULATION
- Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease
- (2011) Stephen D. Wiviott et al. CIRCULATION
- Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes
- (2011) Michelle L. O'Donoghue et al. CIRCULATION
- Ticagrelor Compared With Clopidogrel by Geographic Region in the Platelet Inhibition and Patient Outcomes (PLATO) Trial
- (2011) Kenneth W. Mahaffey et al. CIRCULATION
- 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
- (2011) et al. CIRCULATION
- Pharmacodynamic Evaluation of Pantoprazole Therapy on Clopidogrel Effects
- (2011) José Luis Ferreiro et al. Circulation-Cardiovascular Interventions
- Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease
- (2011) Davide Capodanno et al. Circulation-Cardiovascular Interventions
- A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial
- (2011) D. J. Angiolillo et al. EUROPEAN HEART JOURNAL
- ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
- (2011) et al. EUROPEAN HEART JOURNAL
- Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes
- (2011) Robert F. Storey et al. EUROPEAN HEART JOURNAL
- Platelet Inhibition by Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel in Patients With Acute Myocardial Infarction According to Cytochrome P450 2C19 Genotype
- (2011) In-Suk Kim et al. JACC-Cardiovascular Interventions
- Optimizing Platelet Inhibition in Clopidogrel Poor Metabolizers
- (2011) Dominick J. Angiolillo et al. JACC-Cardiovascular Interventions
- Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention
- (2011) Matthew J. Price JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease
- (2011) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and Exploratory Efficacy of the Novel Thrombin Receptor (PAR-1) Antagonist SCH530348 for Non-ST-Segment Elevation Acute Coronary Syndrome
- (2011) Shinya Goto et al. Journal of Atherosclerosis and Thrombosis
- RECOVERY OF PLATELET FUNCTION FOLLOWING DISCONTINUATION OF PRASUGREL OR CLOPIDOGREL MAINTENANCE DOSING IN ASPIRIN-TREATED SUBJECTS WITH STABLE CORONARY DISEASE: THE RECOVERY TRIAL
- (2011) Matthew J. Price et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clopidogrel–Drug Interactions
- (2011) Eric R. Bates et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- High On-Treatment Platelet Reactivity After Prasugrel Loading Dose and Cardiovascular Events After Percutaneous Coronary Intervention in Acute Coronary Syndromes
- (2011) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prospective Evaluation of On-Clopidogrel Platelet Reactivity Over Time in Patients Treated With Percutaneous Coronary Intervention
- (2011) Gianluca Campo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
- (2011) Glenn N. Levine et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Antiplatelet effects of aspirin vary with level of P2Y12 receptor blockade supplied by either ticagrelor or prasugrel
- (2011) N. S. KIRKBY et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
- (2011) Marie-Germaine Bousser et al. LANCET
- The pharmacogenetics of antiplatelet agents: towards personalized therapy?
- (2011) Tariq Ahmad et al. Nature Reviews Cardiology
- Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
- (2011) Pierluigi Tricoci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluating the Risk-Benefit Profile of the Direct-Acting P2Y12Inhibitor Ticagrelor in Acute Coronary Syndromes
- (2011) Steen Husted POSTGRADUATE MEDICINE
- Inhibición del receptor plaquetario P2Y12 de adenosina difosfato plaquetario: efectos beneficiosos y limitaciones de las estrategias terapéuticas actuales y perspectivas futuras
- (2011) Dominick J. Angiolillo et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy
- (2011) Dominick J. Angiolillo et al. THROMBOSIS AND HAEMOSTASIS
- Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers
- (2010) Kathleen Butler et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Daily administration of the TP receptor antagonist terutroban improved endothelial function in high-cardiovascular-risk patients with atherosclerosis
- (2010) Pierre-François Lesault et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Aspirin Resistance and Compliance with Therapy
- (2010) Jesse Dawson et al. Cardiovascular Therapeutics
- Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function
- (2010) Stefan James et al. CIRCULATION
- Risk Score for In-Hospital Ischemic Stroke Mortality Derived and Validated Within the Get With The Guidelines–Stroke Program
- (2010) Eric E. Smith et al. CIRCULATION
- Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention
- (2010) Philippe Gabriel Steg et al. CIRCULATION
- Basic Principles of Platelet Biology and Clinical Implications
- (2010) Dominick J. Angiolillo et al. CIRCULATION JOURNAL
- First Analysis of the Relation Between CYP2C19 Genotype and Pharmacodynamics in Patients Treated With Ticagrelor Versus Clopidogrel
- (2010) Udaya S. Tantry et al. Circulation-Cardiovascular Genetics
- Adding Cilostazol to Dual Antiplatelet Therapy Achieves Greater Platelet Inhibition than High Maintenance Dose Clopidogrel in Patients With Acute Myocardial Infarction
- (2010) Young-Hoon Jeong et al. Circulation-Cardiovascular Interventions
- Pharmacodynamic Effects of Concomitant Versus Staggered Clopidogrel and Omeprazole Intake
- (2010) José L. Ferreiro et al. Circulation-Cardiovascular Interventions
- Differential Impacts of CYP2C19 Gene Polymorphisms on the Antiplatelet Effects of Clopidogrel and Ticlopidine
- (2010) A Maeda et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies
- (2010) D J Angiolillo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Allergic Reactions to Clopidogrel and Cross-Reactivity to Other Agents
- (2010) Juzar Lokhandwala et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Absorption, Distribution, Metabolism, and Excretion of Ticagrelor in Healthy Subjects
- (2010) R. Teng et al. DRUG METABOLISM AND DISPOSITION
- Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease
- (2010) S. Goto et al. EUROPEAN HEART JOURNAL
- Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
- (2010) Stefan James et al. EUROPEAN HEART JOURNAL
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes
- (2010) Dominick J. Angiolillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Inhibitory Effects of Ticagrelor Compared With Clopidogrel on Platelet Function in Patients With Acute Coronary Syndromes
- (2010) Robert F. Storey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
- (2010) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration
- (2010) Jean-Sébastien Hulot et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clopidogrel Loading Dose Adjustment According to Platelet Reactivity Monitoring in Patients Carrying the 2C19*2Loss of Function Polymorphism
- (2010) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of Cytochrome P450 2C19 Loss-of-Function Polymorphism and of Major Demographic Characteristics on Residual Platelet Function After Loading and Maintenance Treatment With Clopidogrel in Patients Undergoing Elective Coronary Stent Placement
- (2010) Willibald Hochholzer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
- (2010) David R. Holmes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Platelet Aggregation and Its Association With Stent Thrombosis and Bleeding in Clopidogrel-Treated Patients
- (2010) Dirk Sibbing et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
- (2010) Claes Held et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation
- (2010) P. C. J. ARMSTRONG et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
- (2010) Christopher P Cannon et al. LANCET
- Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
- (2010) Shamir R Mehta et al. LANCET
- Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis
- (2010) Jessica L Mega et al. LANCET
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
- (2010) Lars Wallentin et al. LANCET
- Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial
- (2010) Yukito Shinohara et al. LANCET NEUROLOGY
- Paraoxonase-1 is a major determinant of clopidogrel efficacy
- (2010) Heleen J Bouman et al. NATURE MEDICINE
- Clopidogrel with or without Omeprazole in Coronary Artery Disease
- (2010) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Platelet function testing and risk of bleeding complications
- (2010) José Luis Ferreiro et al. THROMBOSIS AND HAEMOSTASIS
- Critical appraisal of a fixed combination of esomeprazole and low dose aspirin in risk reduction
- (2010) Ravi Ravi Vachhani Therapeutics and Clinical Risk Management
- Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: The Early Rapid ReversAl of Platelet ThromboSis with Intravenous Elinogrel before PCI to Optimize REperfusion in Acute Myocardial Infarction (ERASE MI) pilot trial
- (2009) Jeffrey S. Berger et al. AMERICAN HEART JOURNAL
- Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: A randomized, controlled study
- (2009) Yaling Han et al. AMERICAN HEART JOURNAL
- Variability in Responsiveness to Oral Antiplatelet Therapy
- (2009) Dominick J. Angiolillo AMERICAN JOURNAL OF CARDIOLOGY
- Ticagrelor: The First Reversibly Binding Oral P2Y12Receptor Antagonist
- (2009) Steen Husted et al. Cardiovascular Therapeutics
- Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention
- (2009) Marco Valgimigli et al. CIRCULATION
- Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease
- (2009) Paul A. Gurbel et al. CIRCULATION
- Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel
- (2009) Jessica L. Mega et al. CIRCULATION
- Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
- (2009) W. Kuliczkowski et al. EUROPEAN HEART JOURNAL
- Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial
- (2009) Alan D. Michelson et al. EUROPEAN HEART JOURNAL
- Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials
- (2009) M. Valgimigli et al. EUROPEAN HEART JOURNAL
- Platelet thrombin receptor antagonism and atherothrombosis
- (2009) D. J. Angiolillo et al. EUROPEAN HEART JOURNAL
- Unmet needs in oral antiplatelet therapy with ADP receptor blocking agents
- (2009) Steen Husted FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans
- (2009) Nagy A. Farid et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Role of Clopidogrel Loading Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty
- (2009) George Dangas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor binds to human P2Y12independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation
- (2009) J. J. J. VAN GIEZEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to cyp 2c19*2 genotype: first experience in patients
- (2009) P. A. GURBEL et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989–2008)
- (2009) Anaadriana Zakarija et al. KIDNEY INTERNATIONAL
- Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
- (2009) Gilles Montalescot et al. LANCET
- Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study
- (2009) Richard C Becker et al. LANCET
- Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes
- (2009) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intravenous Platelet Blockade with Cangrelor during PCI
- (2009) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelet Inhibition with Cangrelor in Patients Undergoing PCI
- (2009) Robert A. Harrington et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of platelet aggregation with prasugrel and clopidogrel: An integrated analysis in 846 subjects
- (2009) Ying G. Li et al. PLATELETS
- Prasugrel compared with high-dose clopidogrel in acute coronary syndrome
- (2009) G. Montalescot et al. THROMBOSIS AND HAEMOSTASIS
- Cell Adhesion Mechanisms in Platelets
- (2008) David Varga-Szabo et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
- (2008) Stephen D. Wiviott et al. CIRCULATION
- Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial
- (2008) S. A. Murphy et al. EUROPEAN HEART JOURNAL
- A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study
- (2008) D. J. Angiolillo et al. EUROPEAN HEART JOURNAL
- The European Heart Journal: parting thoughts after 6 years of editorship
- (2008) F. Van de Werf EUROPEAN HEART JOURNAL
- Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders
- (2008) Thomas Cuisset et al. JACC-Cardiovascular Interventions
- Aspirin Resistance
- (2008) Dietmar Trenk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
- (2008) Elliott M. Antman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial
- (2008) Stephen D Wiviott et al. LANCET
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now